TBL1XR1 and esophageal cancer: Significantly, ZFP36 strongly reduced VEGF-C mRNA levels in TBL1XR1-overexpressing esophageal cancer cells, resulting in robust inhibition of TBL1XR1-mediated LEC migration and tube formation (Supplementary Fig. 7g–i).